Vig Chandramouli
Partner
Reviewed Updated Jul 27, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
Background
Vig Chandramouli (full name Vignesh Chandramouli) is a Partner at Oak HC/FT, a healthcare and fintech venture and growth-equity firm. He joined the firm in 2014 and focuses on growth-equity and early-stage venture opportunities in healthcare 1. He is based in the New York City metropolitan area 2.
Before Oak HC/FT, Chandramouli was an Associate at LLR Partners, a middle-market growth equity firm, where he concentrated on healthcare services investments 1. He earned dual Bachelor of Science degrees, magna cum laude, from the University of Pennsylvania — one from the Wharton School (Economics and Finance) and one from the School of Engineering and Applied Science (Systems Science & Engineering, with a Math minor) 1.
He was named to the 2023 EVC List of emerging investors by the Emerging Venture Capitalists Association and to Business Insider’s 2024 list of “45 Rising Stars of the Venture Capital Industry” 1. In June 2022 he authored a TechCrunch guest column, “9 ways founders can bring automation to healthcare” 3.
Oak HC/FT does not currently have a Seedlist firm profile.
Stated Thesis
Chandramouli publicly frames his investing around automation, workforce, and “time-to-value” ROI in healthcare. His self-reported focus areas include:
- Healthcare automation across a fragmented value chain. In his 2022 TechCrunch essay, he argued that healthcare — a $4.1 trillion industry — has fallen behind on automation, and that the “constant tug-of-war among patients, payers, providers and pharma” is a source of both cost and startup opportunity 3.
- Workforce beyond physicians. He has repeatedly said clinical-AI startups over-index on doctors while overlooking the majority of the healthcare labor force: “70% of healthcare labor” comes from nurses and allied-health professionals, “with all the margin pressure, that feels like a ripe area for focus” 4.
- Measurable ROI over “burnout reduction.” In late 2025 he told MedCity News that the industry has moved past the first generation of ambient-AI pitches: “Version one … was about burnout, reduction in pajama time … Version two … is all about hard dollar ROI.” He described “time-to-value” as “the number one way to evaluate new AI companies” 5.
- Structural risk-based pricing. He has publicly warned founders that success-based pricing without careful unit economics is dangerous — “If they price, for example, on a success basis, and they’re doing 10 actions and one of them is successful, that’s where you get screwed in the unit economics” 4 — but has also said the founders with the most conviction “will put their fees at risk” tied to a customer ROI cliff 5.
- Epic as a structural constraint. He has advised founders to negotiate around Epic’s product roadmap, noting that customers typically will not sign long-term deals for functionality Epic may ship within 12 months 4.
Inferred Thesis
Chandramouli’s disclosed portfolio (active + prior investments named on his Oak HC/FT page) is overwhelmingly US healthcare, with essentially no fintech exposure despite the firm’s HC/FT dual mandate. Of the 23 companies listed on his firm bio (12 active, 11 prior) 1, all 23 are healthcare businesses — a 100% healthcare concentration by count.
Within healthcare, the portfolio clusters into a few visible patterns (based on the 23 named companies):
- Provider-facing AI and clinical workflow software: Ambience (ambient AI documentation), Notable (clinical automation), Syllable (patient-access AI), Osso VR (surgical training), Reveleer (payer/provider quality software) — roughly 5 of 23 (~22%).
- Workforce and care-model businesses: Stepful (allied-health training), Corner Health (nurse-practitioner primary care — added post-bio update), Main Street Health (rural value-based care), Wayspring (SUD care), Medical Home Network, Aspire Health, VillageMD, CareBridge, InterWell Health — roughly 9 of 23 (~39%) if the value-based care and workforce companies are grouped together.
- Healthcare data / infrastructure / interoperability: Unite Us, Veda, Turquoise Health (co-led 2026 Series C), Trovo Health, Thesis Care, Akido, Core Informatics — a meaningful cluster, though several are ambiguous between “data” and “care model.”
Stage. His verified check-sizing spans from ~$15M seed rounds (Trovo Health, 2024) 6 through mid-eight-figure Series B/C rounds (Stepful $31.5M Series B in 2024 and $55M Series C in 2026 78; Ambience $243M Series C in 2025 9; Turquoise Health $40M Series C in 2026 10). This is consistent with Oak HC/FT’s positioning as a hybrid venture/growth-equity firm rather than a pure seed shop.
Geography. Publicly named companies are US-based (New York, Bay Area, Nashville-cluster health-services). No verified international investments in the disclosed list.
Board pattern. He holds voting board seats at Ambience, Medical Home Network, Osso VR, Stepful, Syllable, and Thesis Care, and observer seats at Main Street Health, Notable, and Reveleer 1 — a heavy operator-engagement footprint even for a growth-oriented investor.
Sample size and caveat. The 23 companies above are the ones Oak HC/FT publicly attributes to him. Actual involvement (as observer vs. lead, historical vs. current) varies, and the “prior investments” bucket includes Oak realizations dating back nearly a decade. Percentages here are computed from that named set, not from a comprehensive deal log.
Portfolio
| Company | Year | Stage | Source |
|---|---|---|---|
| Aspire Health | pre-2018 | prior investment | 1 |
| CareBridge | pre-2024 | prior investment (board observer historical) | 1 |
| Core Informatics | pre-2018 | prior investment | 1 |
| InterWell Health | pre-2022 | prior investment | 1 |
| LDI Integrated Pharmacy | pre-2020 | prior investment | 1 |
| Maestro Health | pre-2018 | prior investment | 1 |
| OncoHealth | pre-2020 | prior investment | 1 |
| Quartet Health | pre-2020 | prior investment (board observer historical) | 1 |
| Therapy Brands | pre-2021 | prior investment | 1 |
| Veda | pre-2022 | prior investment | 1 |
| VillageMD | pre-2022 | prior investment | 1 |
| Syllable | 2020 | board seat (joined board June 2020) | 11 |
| Main Street Health | 2021 | board observer (joined June 2021) | 11 |
| Osso VR | 2022 | board seat (joined March 2022) | 11 |
| Trovo Health | 2024-04-30 | $15M Seed, Oak HC/FT led | 6 |
| Stepful | 2024-11-13 | $31.5M Series B, Oak HC/FT led | 7 |
| Ambience Healthcare | 2025-07-29 | $243M Series C, Oak HC/FT co-led with a16z; on board | 912 |
| Turquoise Health | 2026-03-17 | $40M Series C, Oak HC/FT led | 10 |
| Stepful | 2026-06-11 | $55M Series C, Oak HC/FT led | 8 |
| Corner Health | 2026-07-14 | $32.5M Seed + Series A, Oak HC/FT led Series A | 13 |
| Akido | pre-2024 | active investment (year on firm bio, exact first-check date not publicly attributed to him) | 1 |
| Notable | pre-2024 | active investment (board observer) | 1 |
| Reveleer | pre-2024 | active investment (board observer) | 1 |
| Medical Home Network | pre-2024 | active investment (board seat) | 1 |
| Thesis Care | pre-2024 | active investment (board seat) | 1 |
| Unite Us | pre-2024 | active investment | 1 |
| Wayspring | pre-2024 | active investment | 1 |
Table represents the 23 companies Oak HC/FT publicly attributes to Chandramouli, plus round-level entries where a specific announcement can be cited. Historical rounds for the “prior investment” bucket generally predate detailed public press coverage of his personal deal role, so year fields for those entries are best interpreted as bounds derived from the firm’s disclosures rather than confirmed lead dates.
In Their Own Words
On workforce as an underexplored surface: “But I think this year, with all the margin pressure, that feels like a ripe area for focus.” — MedCity News, Feb 24, 2026 4
On unit economics under success-based pricing: “If they price, for example, on a success basis, and they’re doing 10 actions and one of them is successful, that’s where you get screwed in the unit economics.” — MedCity News, Feb 24, 2026 4
On selling around Epic: “The first question is, is Epic releasing something in 12 months? And if it’s not, then the customer is willing to try, but customers are not willing to sign long-term deals.” — MedCity News, Feb 24, 2026 4
On the evolution of ambient AI: “Version one … was about burnout, reduction in pajama time … Version two … is all about hard dollar ROI.” — MedCity News, Nov 5, 2025 5
On what he now looks for in AI diligence: “This ‘time-to-value’ metric is becoming the number one way to evaluate new AI companies.” — MedCity News, Nov 5, 2025 5
On conviction pricing: “The ones that have conviction … will put their fees at risk. Because if you really do the math, Option A is … a year, and then it maybe converts — or you just give it to them for free until you hit an ROI cliff.” — MedCity News, Nov 5, 2025 5
On why Oak backed Stepful: “What we liked about Stepful was that it is taking people who are hourly workers, in most cases, and getting them into the healthcare field where they have steady salaries and proper benefits.” — TechCrunch, Nov 13, 2024 7
On why Oak backed Ambience: “The market response to Ambience goes beyond customer satisfaction – it reflects genuine customer love.” — Ambience press release, Jul 29, 2025 9
On why Oak led Turquoise: “Turquoise is uniquely positioned at the center of the healthcare economy, leveraging a data moat bolstered by their subject matter expertise, extensive library of over 65,000 contracts and best-in-class user interface.” — Oak HC/FT news post, Mar 17, 2026 10
On why Oak led Corner: “Corner has built a new operating model enabling highly skilled clinicians to practice independently while delivering a better patient experience.” — Pulse 2.0, Jul 14, 2026 13
What Founders Say
No independently sourced founder testimonials specifically about working with Vig Chandramouli were found. Founders in his portfolio (e.g., Carl Madi at Stepful, Michael Ng at Ambience, Lava Sunder at Corner Health) have been quoted in the funding announcements above about their companies and rounds, but not about Chandramouli’s post-investment behavior in a way that would qualify as a direct working-relationship testimonial.
One anonymized portfolio-CEO comment appears on Oak HC/FT’s firm site attributed to Chandramouli’s engagement style — “He goes deep and works shoulder-to-shoulder with us to get things done” 1 — but as a firm-published testimonial without a named attribution it is best treated as marketing rather than independent founder feedback.
Connections
- Board Director — Ambience Healthcare (joined at Series C, July 2025) 912
- Board Director — Medical Home Network 1
- Board Director — Osso VR (joined March 2022) 11
- Board Director — Stepful 7
- Board Director — Syllable (joined June 2020) 11
- Board Director — Thesis Care 1
- Board Observer — Main Street Health (joined June 2021) 11
- Board Observer — Notable 1
- Board Observer — Reveleer 1
- Co-investors on Ambience Series C: Andreessen Horowitz (Julie Yoo, co-lead), OpenAI Startup Fund, Kleiner Perkins, Optum Ventures, Frist Cressey Ventures, Town Hall Ventures, Smash Capital, Georgian, Founders Circle Capital 9
- Co-investors on Stepful Series B/C: Y Combinator, Reach Capital, AlleyCorp, Foresite Capital, Hearst Ventures, Citi Impact Fund, SemperVirens, Intermountain Health, ECMC Education Impact Fund 78
- Co-investors on Trovo Health Seed: Y Combinator, Reach Capital, AlleyCorp, SemperVirens, Company Ventures, Green Sands, ECMC Education Impact Fund, Intermountain Ventures. Oak co-founder Andrew Adams took the board seat at Trovo, not Chandramouli 6.
- Co-investors on Turquoise Health Series C: Andreessen Horowitz, Adams Street Partners, Yosemite 10
- Co-investors on Corner Health Series A: First Round Capital, Zigg Capital, Homebrew, Pathlight Ventures, Wischoff Ventures, Go Global Ventures 13
- Prior employer: LLR Partners (Associate, healthcare services), pre-2014 1
- Education/network: University of Pennsylvania — Wharton and SEAS 1
Sources
-
“Vig Chandramouli,” Oak HC/FT team page. Accessed July 2026. https://www.oakhcft.com/team-members/vig-chandramouli↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩
-
“Vig Chandramouli — Oak HC/FT,” LinkedIn profile. Accessed July 2026. https://www.linkedin.com/in/vchandramouli↩
-
Vig Chandramouli, “9 ways founders can bring automation to healthcare,” TechCrunch, June 22, 2022. Referenced via LatestLY summary. https://www.latestly.com/socially/technology/9-ways-founders-can-bring-automation-to-healthcare-latest-tweet-by-techcrunch-3858741.html↩↩
-
Marissa Plescia, “4 Health Tech Trends Startups Can’t Ignore, Per an Oak HC/FT Partner,” MedCity News, February 24, 2026. https://medcitynews.com/2026/02/healthcare-technology-startup-investment/↩↩↩↩↩↩
-
MedCity News, “Why ‘Time-to-Value’ Is the #1 Metric Healthcare AI Customers Care About,” November 5, 2025. https://medcitynews.com/2025/11/healthcare-digital-health-investment-ai/↩↩↩↩↩
-
“Trovo Health Announces $15 Million Seed Funding Round Led by Oak HC/FT,” BusinessWire, April 30, 2024. https://www.businesswire.com/news/home/20240430947713/en/Trovo-Health-Announces-$15-Million-Seed-Funding-Round-Led-by-Oak-HCFT↩↩↩
-
Marissa Kwiatkowski, “Stepful raises $31.5M to address healthcare staffing shortage with AI-powered training,” TechCrunch, November 13, 2024. https://techcrunch.com/2024/11/13/stepful-raises-31-5m-to-address-healthcare-staffing-shortage-with-ai-powered-training/↩↩↩↩↩
-
“Stepful Announces $55M Series C to Scale Its AI-Powered Training Platform Across the Healthcare Workforce,” The AI Insider, June 11, 2026. https://theaiinsider.tech/2026/06/11/stepful-announces-55m-series-c-to-scale-its-ai-powered-training-platform-across-the-healthcare-workforce/↩↩↩
-
“Ambience Healthcare Announces $243 Million Series C to Scale its AI Platform for Health Systems,” Ambience Healthcare blog, July 29, 2025. https://www.ambiencehealthcare.com/blog/ambience-healthcare-announces-243-million-series-c-to-scale-its-ai-platform-for-health-systems↩↩↩↩↩
-
“Turquoise Health Announces $40 Million Series C to Become the Operating System for Healthcare Contracts and Payments,” Oak HC/FT news, March 17, 2026. https://www.oakhcft.com/news/turquoise-health-announces-40-million-series-c-to-become-the-operating-system-for-healthcare-contracts-and-payments↩↩↩↩
-
Board-seat start dates confirmed via search summaries of Vignesh Chandramouli’s profiles on The Org and Equilar ExecAtlas. Accessed July 2026. https://theorg.com/org/oak-hcft/org-chart/vig-chandramouli↩↩↩↩↩↩
-
Vig Chandramouli, LinkedIn post announcing Oak’s co-lead of Ambience’s Series C alongside a16z, and his own board seat. Accessed July 2026. https://www.linkedin.com/posts/vchandramouli_im-honored-to-share-that-oak-has-co-led-activity-7356080922909118465-FkFZ↩↩
-
“Corner Health Raises $32.5 Million in Seed and Series A Financing to Rebuild Primary Care,” Pulse 2.0, July 14, 2026. https://pulse2.com/corner-health-raises-32-5-million-in-seed-and-series-a-financing-to-rebuild-primary-care/↩↩↩